California Assembly Bill 339 aims to rein in prescription-drug prices to ease the economic impact on those with chronic medical conditions who need expensive drugs, but critics are warning that it also would increase insurance premiums for everyone else and make it harder for insurers to obtain lower-cost drugs. Read More »

Gerresheimer AG, a partner to the pharma and health care industry worldwide, announced today it will extend its pharmaceutical packaging business with the acquisition of Centor US Holding, Inc. Read More »

Data from the 2014 United Benefit Advisors (UBA) Health Plan Survey released Tuesday shows a substantial increase in the use of 4-tier plans that usually cover the highest cost drugs and major increases in corresponding median copays. Read More »

Deal includes more than 200 offices specializing in occupational health, medical exams and urgent care Read More »

Atlantic Information Services, leaders from SCAN and Express Scripts and a consultant with industry experience will explain how they were able to achieve strong results from their joint MA-PBM program during a webinar on Aug. 6. Read More »

Praxsyn Corp. today announced that the board of directors has appointed Justin Cary as the company's chief financial officer, effective immediately. Read More »

Teva Pharmaceutical Industries, Ltd. announced Monday it has signed a definitive agreement with Allergan, PLC to acquire Allergan Generics in a transaction valued at $40.5 billion.The strategic acquisition brings together two leading generics businesses with complementary strengths, brands and cultures. Read More »

Rite Aid has recently collaborated with HealthSpot to deploy telepresence pharmacy kiosks at 25 Rite Aid pharmacies across Ohio. Read More »

The U.S. Food and Drug Administration late last week approved Praluent injections, the first cholesterol-lowering treatment cleared for use in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors. Read More »

Covance Drug Development recently relocated its Dallas clinical research unit to a new, fit-for-purpose clinical research facility in the same building. Read More »

Mike Pritts, executive vice president of product innovation at Surescripts, recently wrote a blog post touting the importance of IT automation to the healthcare industry. Read More »

Optum and Catamaran Corporation, both pharmaceutical companies, recently completed a combining of the two businesses. Read More »

The nation's first integrative pharmacy chain, Pharmaca Integrative Pharmacy, recently announced it will team up with Diplomat Pharmacy Inc. to offer patients access to specialty care services. Read More »

The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences (ACPHS) will host a symposium and workshop exploring the latest advances in the field of nanomedicine on from Aug. 3 to 7. Read More »

Hewitt W. "Ted" Matthews, longtime dean of Mercer University's College of Pharmacy, was recently presented with the Larry L. Braden Meritorious Service Award from the Georgia Pharmacy Association (GPhA). Read More »

ScripsAmerica Inc. announced on Thursday that the company's specialty pharmacy operations logged $2.23 million in approved orders during the months of May and June. Read More »

Retail Management Solutions recently released a free e-book titled "A Pharmacy Owner’s Guide to Point of Sale Security." Read More »

National Health Expenditures (NHE) spending was up 5 percent in 2014 and most recently, health spending was up 7.5 percent in the first quarter of 2015, according to estimates by the Altarum Center for Sustainable Health Spending, but will this trend continue? Read More »

The International Academy of Compounding Pharmacists (IACP) recently released its formal comments about its concerns over the proposed U.S. Food and Drug Administration (FDA) memorandum of understanding. Read More »

Dr. Steve Miller, the chief medical officer of Express Scripts, recently discussed a variety of specialty pharmacy trends, such as the loss of social contract within drug pricing, with Evidence-Based Diabetes Management. Read More »